There is no single guideline-backed protocol for this.

Official guidance says only to stop combined pills at 50 and switch to a non-hormonal method or a progestogen-only method, without detailing how or in what order. In practice, clinicians build individualized bridges depending on whether contraception is still needed: options include changing which estrogen or progestin is used while staying on an oral method, adding a hormone therapy patch alongside a progestogen-only pill or an IUD, or, if contraception is no longer needed, stopping the pill and starting estrogen therapy with a delay before adding progesterone. The first and most important question in any of these plans is simply whether pregnancy is still a possibility for you.

What to know about this answer

The most detailed switching protocols in the source material come from individual clinicians' field practice rather than from any guideline, and one specific piece of guidance (favoring oral hormone therapy for women who tolerated oral contraceptives well) is flagged as potentially in tension with clotting-risk data.

What the research shows, and which source each finding rests on

The core guideline instruction is limited to stop combined hormonal contraception at age 50 and switch to a non-hormonal method or a progestogen-only method (implant, pill, or hormonal IUD); it does not specify a sequence, washout, or age-44 protocol.

A[1]

Standard hormone therapy does not stop ovulation, so if a woman still needs contraception, switching to hormone therapy alone does not provide it; a separate contraceptive method or an established non-fertile status is required.

A[1]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

match the new regimen to what she already tolerated well

one clinician's field practice

If a woman has done well for years on a particular progestin, this clinician keeps that same progestin when switching her estrogen, changing one variable at a time; and for women who tolerated oral contraceptives well for decades with no clot history, this clinician considers continuing an oral combined hormone therapy option.

E[2]

prior tolerance of oral contraceptives does not establish that oral hormone therapy is the lower-risk choice now

the clotting-risk research

A large case-control study found oral menopausal hormone therapy carried roughly a 4-fold clot risk in women over 50, while non-oral (transdermal) hormone therapy carried no increased risk; age is the variable that changed between when she started the pill and now, so past tolerance of an oral method does not by itself argue for staying oral.

C[3]

What would settle it: No trial has tested any of the switching strategies described in the field against each other or against simply continuing combined contraception. This is named directly as a gap in the source material.

What is really going on here

  1. Whether contraception is still needed is the first branch point in any switching plan, since it changes which options are even on the table.
  2. None of the field-described switching strategies (staying oral with a different estrogen, adding a patch to a progestogen-only pill, adding a patch to an IUD, or a full staggered switch) has been directly compared to continuing the original combined pill in a trial.

Questions for your doctor

  1. Do I still need contraception, and how does that change our options?
  2. What specific sequence would you recommend for switching me, and why that order?
  3. Given my history on my current pill, would you keep any part of it the same?
  4. What would we watch for in the weeks after a switch to know if it is working?

Questions with no answer yet

Does matching a woman's new progestin to the one she already tolerated well on the pill actually produce better outcomes than switching progestins freely, or is this untested clinical craft?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The progestin-continuity approach, keeping the same progestin and changing only the estrogen, is described as field practice reasoned from prior tolerance, not from any trial comparing it against other switching strategies.

What would test it: A trial comparing progestin-continuity switching against free progestin switching, measuring symptom control, tolerability, and satisfaction.

For a woman who tolerated oral contraceptives well for decades, does that history actually predict she will also tolerate oral menopausal hormone therapy well now that she is over 50?

Studied and negative

What is known: A large case-control study found oral menopausal hormone therapy carried roughly a 4-fold clot risk in women over 50, while non-oral, transdermal hormone therapy carried no increased risk; age is the variable that changed between when a woman started tolerating oral contraceptives and now, so her earlier tolerance does not establish that oral is the lower-risk choice at her current age.

What would test it: A study specifically comparing clot outcomes in women over 50 stratified by whether they previously tolerated oral contraceptives well, to see whether that history actually predicts anything about current oral hormone therapy risk.

Sources

  1. 1.FSRH. Contraception for Women Aged Over 40 Years. Guideline, August 2017 (amended September 2019, further amended July 2023).Systematic review or guideline
  2. 2.Heather Hirsch, MD. Is Your Birth Control Making Perimenopause Worse? When to Switch to HRT (video transcript).Review, opinion or mechanism
  3. 3.The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.Roach REJ, Lijfering WM, Helmerhorst FM, Cannegieter SC, Rosendaal FR, van Hylckama Vlieg A. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. J Thromb Haemost 2013;11(1):124-31. · Observational study

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides